8-K - Anika Therapeutics, Inc. (0000898437) (Filer)
Published . Updated .
Key takeaways
- 8-K - Anika Therapeutics filed an 8-K with the SEC on Nov 6 (a notice of a material company event).
- Exposed: ANIK
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Anika Therapeutics filed an 8-K with the SEC on Nov 6 (a notice of a material company event).
Directly affected
- ANIK Anika Therapeutics
Named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ANIK | +8.45% | +0.80% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-06 AccNo: 0001171843-26-007211 Size: 443 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far Anika Therapeutics (ANIK) has moved since 6 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| Anika Therapeutics (ANIK) | three days earlier | +0.80% | final price |
| Anika Therapeutics (ANIK) | five days earlier | +8.45% | final price |
Who gains and who loses around Anika Therapeutics (ANIK)
Companies tied to this story
- ANIK Anika Therapeutics
In “8-K - Anika Therapeutics, Inc. (0000898437) (Filer),” Anika Therapeutics (ANIK) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> ANIK
How “8-K - Anika Therapeutics, Inc. (0000898437) (Filer)” reaches Anika Therapeutics (ANIK)
The 6 Nov 2026 story “8-K - Anika Therapeutics, Inc. (0000898437) (Filer)” names Anika Therapeutics (ANIK) because of this story.
What ties Anika Therapeutics (ANIK) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> ANIK
What the saved facts support for Anika Therapeutics (ANIK)
14 out of 100
“8-K - Anika Therapeutics, Inc. (0000898437) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.